CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR

Go back to CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
Cytosorbents Corporation (NASDAQ: CTSO) Delayed: 0.36 +0.01 (2.86%)
Previous Close $0.35    52 Week High $7.48 
Open $0.36    52 Week Low $3.11 
Day High $0.36    P/E N/A 
Day Low $0.35    EPS $-0.03 
Volume 37,505